MURUGAPPAN M, et al. “ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 4, Apr. 2025, pp. 44-51, doi:10.22159/ajpcr.2025v18i4.54004.